X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
https://www.globenewswire.com/news-release/2022/06/01/2454378/0/en/Chiesi-USA-Announces-First-Analysis-from-the-CAMEO-Registry-Assessing-KENGREAL-cangrelor-Use-and-Transition-to-Oral-P2Y12-Inhibitors-in-Routine-Clinical-Practice.html
https://www.globenewswire.com/news-release/2022/01/25/2372632/0/en/Chiesi-USA-Announces-New-Publication-of-Post-Hoc-Analysis-on-Timing-of-Ischemic-Events-in-Cardiac-Patients-and-Role-of-KENGREAL-cangrelor-in-Reducing-Risk.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213356
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213551
https://www.biospace.com/article/releases/chiesi-usa-announces-publication-of-cost-consequence-analysis-of-kengreal-cangrelor-in-cardiac-patients-at-high-risk-of-complications-following-pci-in-the-american-journal-of-cardiovascular-drugs/
https://www.biospace.com/article/releases/chiesi-usa-announces-publication-of-cost-consequence-analysis-of-kengreal-cangrelor-in-cardiac-patients-at-high-risk-of-complications-following-pci-in-the-american-journal-of-cardiovascular-drugs/
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-kengreal-204958-cangrelor-for-injection-50-mgvial-1564811115.pdf
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/003773/WC500188101.pdf
http://www.biospace.com/News/the-medicines-companys-kengreal-gets-fda-support/372042/source=TopBreaking
http://www.pmlive.com/pharma_news/antibiotics_among_7_new_drugs_backed_by_ema_637340
http://www.fiercebiotech.com/story/medicines-cos-fda-rejected-cardio-drug-finds-eu-success/2015-01-23
http://ir.themedicinescompany.com/phoenix.zhtml?c=122204&p=irol-newsArticle&ID=2009965
Market Place
Share 
